News | March 13, 2022
Japan tops CPhI ‘API Quality’ ranking for second year
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Covaxin is not approved in the USA for any age group
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Subscribe To Our Newsletter & Stay Updated
